EPIGENOMICS-UK 润色咨询

Epigenomics

出版年份:2009 年文章数:1126 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:4.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2142459, encodeId=9bf6214245903, content=接收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:38:01 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=580541, encodeId=07e1580541c9, content=请问这个杂志要求必须只有一个通讯吗<span class="quote">醉卧青山 2018-02-27 11:09:00 发表:<br>刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。</span>, beContent=醉卧青山 2018-02-27 11:09:00 发表: 刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/16/54df55eebe794de374ad418758568b1b.jpg, createdBy=7de92417989, createdName=136238d9f5m, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923761, encodeId=4c36923e61bc, content=为什么找不到杂志官网呢,点击进去是宣传大肠癌血液检查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bee5459632, createdName=HSKEHS, createdTime=Mon Feb 08 21:33:37 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582771, encodeId=1f3c582e718f, content=请问后来多久有回复啊,under consideration送外审了么?<span class="quote">h7anna111 2018-03-14 09:09:00 发表:<br>各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!</span>, beContent=h7anna111 2018-03-14 09:09:00 发表: 各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6005191681, createdName=1037657937_23630378, createdTime=Mon Jan 06 00:00:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传;生信<br>经验分享:想知道不加速的话 全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取 可以不交版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位,如果没选择加速出版的话一般一审多久?我1月份投稿,未选择加速出版和开源,投稿一周后状态从under consideration变成under review,现在under review状态持续差不多四周了,还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神,投稿5天,一直处于under consideration~是怎么个意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=)]
    2023-06-12 ms9000001377282776 来自广东省

    接收纯生信吗

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2142459, encodeId=9bf6214245903, content=接收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:38:01 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=580541, encodeId=07e1580541c9, content=请问这个杂志要求必须只有一个通讯吗<span class="quote">醉卧青山 2018-02-27 11:09:00 发表:<br>刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。</span>, beContent=醉卧青山 2018-02-27 11:09:00 发表: 刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/16/54df55eebe794de374ad418758568b1b.jpg, createdBy=7de92417989, createdName=136238d9f5m, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923761, encodeId=4c36923e61bc, content=为什么找不到杂志官网呢,点击进去是宣传大肠癌血液检查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bee5459632, createdName=HSKEHS, createdTime=Mon Feb 08 21:33:37 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582771, encodeId=1f3c582e718f, content=请问后来多久有回复啊,under consideration送外审了么?<span class="quote">h7anna111 2018-03-14 09:09:00 发表:<br>各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!</span>, beContent=h7anna111 2018-03-14 09:09:00 发表: 各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6005191681, createdName=1037657937_23630378, createdTime=Mon Jan 06 00:00:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传;生信<br>经验分享:想知道不加速的话 全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取 可以不交版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位,如果没选择加速出版的话一般一审多久?我1月份投稿,未选择加速出版和开源,投稿一周后状态从under consideration变成under review,现在under review状态持续差不多四周了,还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神,投稿5天,一直处于under consideration~是怎么个意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=)]
    2019-11-27 136238d9f5m

    请问这个杂志要求必须只有一个通讯吗醉卧青山 2018-02-27 11:09:00 发表:
    刚刚online了一篇,来谈谈感想:
    1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。
    2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。

    醉卧青山 2018-02-27 11:09:00 发表: 刚刚online了一篇,来谈谈感想:
    1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。
    2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2142459, encodeId=9bf6214245903, content=接收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:38:01 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=580541, encodeId=07e1580541c9, content=请问这个杂志要求必须只有一个通讯吗<span class="quote">醉卧青山 2018-02-27 11:09:00 发表:<br>刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。</span>, beContent=醉卧青山 2018-02-27 11:09:00 发表: 刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/16/54df55eebe794de374ad418758568b1b.jpg, createdBy=7de92417989, createdName=136238d9f5m, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923761, encodeId=4c36923e61bc, content=为什么找不到杂志官网呢,点击进去是宣传大肠癌血液检查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bee5459632, createdName=HSKEHS, createdTime=Mon Feb 08 21:33:37 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582771, encodeId=1f3c582e718f, content=请问后来多久有回复啊,under consideration送外审了么?<span class="quote">h7anna111 2018-03-14 09:09:00 发表:<br>各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!</span>, beContent=h7anna111 2018-03-14 09:09:00 发表: 各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6005191681, createdName=1037657937_23630378, createdTime=Mon Jan 06 00:00:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传;生信<br>经验分享:想知道不加速的话 全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取 可以不交版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位,如果没选择加速出版的话一般一审多久?我1月份投稿,未选择加速出版和开源,投稿一周后状态从under consideration变成under review,现在under review状态持续差不多四周了,还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神,投稿5天,一直处于under consideration~是怎么个意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=)]
    2021-02-08 HSKEHS

    为什么找不到杂志官网呢,点击进去是宣传大肠癌血液检查的

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2142459, encodeId=9bf6214245903, content=接收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:38:01 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=580541, encodeId=07e1580541c9, content=请问这个杂志要求必须只有一个通讯吗<span class="quote">醉卧青山 2018-02-27 11:09:00 发表:<br>刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。</span>, beContent=醉卧青山 2018-02-27 11:09:00 发表: 刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/16/54df55eebe794de374ad418758568b1b.jpg, createdBy=7de92417989, createdName=136238d9f5m, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923761, encodeId=4c36923e61bc, content=为什么找不到杂志官网呢,点击进去是宣传大肠癌血液检查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bee5459632, createdName=HSKEHS, createdTime=Mon Feb 08 21:33:37 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582771, encodeId=1f3c582e718f, content=请问后来多久有回复啊,under consideration送外审了么?<span class="quote">h7anna111 2018-03-14 09:09:00 发表:<br>各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!</span>, beContent=h7anna111 2018-03-14 09:09:00 发表: 各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6005191681, createdName=1037657937_23630378, createdTime=Mon Jan 06 00:00:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传;生信<br>经验分享:想知道不加速的话 全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取 可以不交版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位,如果没选择加速出版的话一般一审多久?我1月份投稿,未选择加速出版和开源,投稿一周后状态从under consideration变成under review,现在under review状态持续差不多四周了,还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神,投稿5天,一直处于under consideration~是怎么个意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=)]
    2020-01-06 1037657937_23630378

    请问后来多久有回复啊,under consideration送外审了么?h7anna111 2018-03-14 09:09:00 发表:
    各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!

    h7anna111 2018-03-14 09:09:00 发表: 各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2142459, encodeId=9bf6214245903, content=接收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:38:01 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=580541, encodeId=07e1580541c9, content=请问这个杂志要求必须只有一个通讯吗<span class="quote">醉卧青山 2018-02-27 11:09:00 发表:<br>刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。</span>, beContent=醉卧青山 2018-02-27 11:09:00 发表: 刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/16/54df55eebe794de374ad418758568b1b.jpg, createdBy=7de92417989, createdName=136238d9f5m, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923761, encodeId=4c36923e61bc, content=为什么找不到杂志官网呢,点击进去是宣传大肠癌血液检查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bee5459632, createdName=HSKEHS, createdTime=Mon Feb 08 21:33:37 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582771, encodeId=1f3c582e718f, content=请问后来多久有回复啊,under consideration送外审了么?<span class="quote">h7anna111 2018-03-14 09:09:00 发表:<br>各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!</span>, beContent=h7anna111 2018-03-14 09:09:00 发表: 各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6005191681, createdName=1037657937_23630378, createdTime=Mon Jan 06 00:00:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传;生信<br>经验分享:想知道不加速的话 全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取 可以不交版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位,如果没选择加速出版的话一般一审多久?我1月份投稿,未选择加速出版和开源,投稿一周后状态从under consideration变成under review,现在under review状态持续差不多四周了,还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神,投稿5天,一直处于under consideration~是怎么个意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=)]
    2021-12-28 乌云背后的幸福线

    哪些期刊是公认的水刊?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2142459, encodeId=9bf6214245903, content=接收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:38:01 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=580541, encodeId=07e1580541c9, content=请问这个杂志要求必须只有一个通讯吗<span class="quote">醉卧青山 2018-02-27 11:09:00 发表:<br>刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。</span>, beContent=醉卧青山 2018-02-27 11:09:00 发表: 刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/16/54df55eebe794de374ad418758568b1b.jpg, createdBy=7de92417989, createdName=136238d9f5m, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923761, encodeId=4c36923e61bc, content=为什么找不到杂志官网呢,点击进去是宣传大肠癌血液检查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bee5459632, createdName=HSKEHS, createdTime=Mon Feb 08 21:33:37 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582771, encodeId=1f3c582e718f, content=请问后来多久有回复啊,under consideration送外审了么?<span class="quote">h7anna111 2018-03-14 09:09:00 发表:<br>各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!</span>, beContent=h7anna111 2018-03-14 09:09:00 发表: 各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6005191681, createdName=1037657937_23630378, createdTime=Mon Jan 06 00:00:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传;生信<br>经验分享:想知道不加速的话 全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取 可以不交版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位,如果没选择加速出版的话一般一审多久?我1月份投稿,未选择加速出版和开源,投稿一周后状态从under consideration变成under review,现在under review状态持续差不多四周了,还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神,投稿5天,一直处于under consideration~是怎么个意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=)]
    2021-12-28 小动量

    选刊时有哪些需要避免的雷区?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2142459, encodeId=9bf6214245903, content=接收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:38:01 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=580541, encodeId=07e1580541c9, content=请问这个杂志要求必须只有一个通讯吗<span class="quote">醉卧青山 2018-02-27 11:09:00 发表:<br>刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。</span>, beContent=醉卧青山 2018-02-27 11:09:00 发表: 刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/16/54df55eebe794de374ad418758568b1b.jpg, createdBy=7de92417989, createdName=136238d9f5m, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923761, encodeId=4c36923e61bc, content=为什么找不到杂志官网呢,点击进去是宣传大肠癌血液检查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bee5459632, createdName=HSKEHS, createdTime=Mon Feb 08 21:33:37 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582771, encodeId=1f3c582e718f, content=请问后来多久有回复啊,under consideration送外审了么?<span class="quote">h7anna111 2018-03-14 09:09:00 发表:<br>各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!</span>, beContent=h7anna111 2018-03-14 09:09:00 发表: 各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6005191681, createdName=1037657937_23630378, createdTime=Mon Jan 06 00:00:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传;生信<br>经验分享:想知道不加速的话 全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取 可以不交版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位,如果没选择加速出版的话一般一审多久?我1月份投稿,未选择加速出版和开源,投稿一周后状态从under consideration变成under review,现在under review状态持续差不多四周了,还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神,投稿5天,一直处于under consideration~是怎么个意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=)]
    2021-09-03 sunnysx

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:表观遗传;生信
    经验分享:想知道不加速的话 全流程得多久啊····

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2142459, encodeId=9bf6214245903, content=接收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:38:01 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=580541, encodeId=07e1580541c9, content=请问这个杂志要求必须只有一个通讯吗<span class="quote">醉卧青山 2018-02-27 11:09:00 发表:<br>刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。</span>, beContent=醉卧青山 2018-02-27 11:09:00 发表: 刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/16/54df55eebe794de374ad418758568b1b.jpg, createdBy=7de92417989, createdName=136238d9f5m, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923761, encodeId=4c36923e61bc, content=为什么找不到杂志官网呢,点击进去是宣传大肠癌血液检查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bee5459632, createdName=HSKEHS, createdTime=Mon Feb 08 21:33:37 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582771, encodeId=1f3c582e718f, content=请问后来多久有回复啊,under consideration送外审了么?<span class="quote">h7anna111 2018-03-14 09:09:00 发表:<br>各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!</span>, beContent=h7anna111 2018-03-14 09:09:00 发表: 各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6005191681, createdName=1037657937_23630378, createdTime=Mon Jan 06 00:00:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传;生信<br>经验分享:想知道不加速的话 全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取 可以不交版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位,如果没选择加速出版的话一般一审多久?我1月份投稿,未选择加速出版和开源,投稿一周后状态从under consideration变成under review,现在under review状态持续差不多四周了,还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神,投稿5天,一直处于under consideration~是怎么个意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=)]
    2019-11-16 momoxiaogu

    不开放获取 可以不交版面费吗?

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2142459, encodeId=9bf6214245903, content=接收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:38:01 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=580541, encodeId=07e1580541c9, content=请问这个杂志要求必须只有一个通讯吗<span class="quote">醉卧青山 2018-02-27 11:09:00 发表:<br>刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。</span>, beContent=醉卧青山 2018-02-27 11:09:00 发表: 刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/16/54df55eebe794de374ad418758568b1b.jpg, createdBy=7de92417989, createdName=136238d9f5m, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923761, encodeId=4c36923e61bc, content=为什么找不到杂志官网呢,点击进去是宣传大肠癌血液检查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bee5459632, createdName=HSKEHS, createdTime=Mon Feb 08 21:33:37 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582771, encodeId=1f3c582e718f, content=请问后来多久有回复啊,under consideration送外审了么?<span class="quote">h7anna111 2018-03-14 09:09:00 发表:<br>各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!</span>, beContent=h7anna111 2018-03-14 09:09:00 发表: 各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6005191681, createdName=1037657937_23630378, createdTime=Mon Jan 06 00:00:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传;生信<br>经验分享:想知道不加速的话 全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取 可以不交版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位,如果没选择加速出版的话一般一审多久?我1月份投稿,未选择加速出版和开源,投稿一周后状态从under consideration变成under review,现在under review状态持续差不多四周了,还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神,投稿5天,一直处于under consideration~是怎么个意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=)]
    2021-03-02 ms7000000876347523

    请问各位,如果没选择加速出版的话一般一审多久?我1月份投稿,未选择加速出版和开源,投稿一周后状态从under consideration变成under review,现在under review状态持续差不多四周了,还是一点动静没有。

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2142459, encodeId=9bf6214245903, content=接收纯生信吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9048588526, createdName=ms9000001377282776, createdTime=Mon Jun 12 22:38:01 CST 2023, time=2023-06-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=580541, encodeId=07e1580541c9, content=请问这个杂志要求必须只有一个通讯吗<span class="quote">醉卧青山 2018-02-27 11:09:00 发表:<br>刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。</span>, beContent=醉卧青山 2018-02-27 11:09:00 发表: 刚刚online了一篇,来谈谈感想: <br> 1.该杂志侧重于生物信息分析,通俗来说就是以表观(DNA甲基化、组蛋白修饰、non-coding RNA,染色质结构等)为主的各种组学,可配合转录组和基因组。湿实验方面,配少量形态学、流式和qPCR验证的小实验即可,不需要生信分析后续的功能验证实验。 <br> 2.该杂志提供按出版页数付费的加速审稿服务(文章不accept的话,不会收费),六周就能完成从投稿到送审、修回、校对、online的过程(亲测,五周半就online,如果不是校对问题太大的话五周就online了)。如果你的时间紧迫,可以试试。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/16/54df55eebe794de374ad418758568b1b.jpg, createdBy=7de92417989, createdName=136238d9f5m, createdTime=Wed Nov 27 00:00:00 CST 2019, time=2019-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=923761, encodeId=4c36923e61bc, content=为什么找不到杂志官网呢,点击进去是宣传大肠癌血液检查的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=118, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bee5459632, createdName=HSKEHS, createdTime=Mon Feb 08 21:33:37 CST 2021, time=2021-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582771, encodeId=1f3c582e718f, content=请问后来多久有回复啊,under consideration送外审了么?<span class="quote">h7anna111 2018-03-14 09:09:00 发表:<br>各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!</span>, beContent=h7anna111 2018-03-14 09:09:00 发表: 各位好,我投了一篇,一个月多了,一直是under consideration,请问大家这个期刊的status一直是under consideration么,因为网上有的同行说有的杂志一直就是这个状态,恳请投过的亲们告知一声,不是的话我准备写信催下编辑,谢谢!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6005191681, createdName=1037657937_23630378, createdTime=Mon Jan 06 00:00:00 CST 2020, time=2020-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103728, encodeId=b3691103e28d8, content=哪些期刊是公认的水刊?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103727, encodeId=cf7b1103e27fa, content=选刊时有哪些需要避免的雷区?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014215, encodeId=5e6c101421588, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:表观遗传;生信<br>经验分享:想知道不加速的话 全流程得多久啊····, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24591642868, createdName=sunnysx, createdTime=Fri Sep 03 09:39:18 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579984, encodeId=13c85e998471, content=不开放获取 可以不交版面费吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=06a41689219, createdName=momoxiaogu, createdTime=Sat Nov 16 00:00:00 CST 2019, time=2019-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944688, encodeId=c2469446887d, content=请问各位,如果没选择加速出版的话一般一审多久?我1月份投稿,未选择加速出版和开源,投稿一周后状态从under consideration变成under review,现在under review状态持续差不多四周了,还是一点动静没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78ee5383123, createdName=ms7000000876347523, createdTime=Tue Mar 02 10:25:13 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949586, encodeId=1c839495860a, content=请问各位大神,投稿5天,一直处于under consideration~是怎么个意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e3ad5471158, createdName=ms2000001884403772, createdTime=Fri Mar 19 21:23:49 CST 2021, time=2021-03-19, status=1, ipAttribution=)]
    2021-03-19 ms2000001884403772

    请问各位大神,投稿5天,一直处于under consideration~是怎么个意思?

    1

    展开1条回复
共171条页码: 2/18页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分